Canada’s healthcare industry is a $160 billion industry
and it is growing. AIM is one of few opportunities for investors
to participate in this large, recession proof industry.
AIM’s integrated approach to wellness works with both
public and private sector payors; expanding its market reach
and diminishing its reliance on a single customer base.
AIM has a strong market position for a number of reasons:
- It is Canada’s largest private-sector supplier
of intravenous infusions;
- It is Canada’s largest provider of medically-based
chronic pain management therapies;
- Its integrated approach to wellness offers patients
a continuum of care unmatched in the industry;
- It has numerous, deep relationships with pharmaceutical
companies; and
- It has a twenty year history of growth.
Partnerships and Acquisitions
Email
: partnerships@aimhealthgroup.com
